Search results
Showing 1 to 7 of 7 results for baloxavir marboxil
NICE is unable to make a recommendation on baloxavir marboxil (Xofluza) for treating and preventing influenza in children 1 to 11 years. This is because the company did not provide an evidence submission.
Show all sections
Sections for TA1135
NICE is unable to make a recommendation on baloxavir marboxil (Xofluza) for treating acute uncomplicated influenza in people aged 12 and over. This is because Roche did not provide an evidence submission.
Show all sections
Sections for TA732
Awaiting development Reference number: GID-TA12479 Expected publication date: TBC
Awaiting development Reference number: GID-TA10683 Expected publication date: TBC
Baloxavir marboxil for preventing influenza in people 12 years and over [ID3793]
In development Reference number: GID-TA10684 Expected publication date: TBC
Baloxavir marboxil for treating and preventing influenza in babies 3 weeks to under 1 year [ID6555]
Discontinued Reference number: GID-TA11712
In development Reference number: GID-TA11646 Expected publication date: TBC